<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01403194</url>
  </required_header>
  <id_info>
    <org_study_id>10-004698</org_study_id>
    <nct_id>NCT01403194</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure and Cardiometabolic Risk</brief_title>
  <official_title>Impact of Treatment of Sleep Disordered Breathing With Continuous Positive Airway Pressure (CPAP) on Cardiometabolic Risk Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis for this study is that children with sleep disordered breathing will benefit
      from treatment with Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway
      Pressure (BiPAP) in terms of reduction in cardiovascular risk markers and insulin resistance.

      The CPAP machine delivers a predetermined level of pressure. It releases a stream of
      compressed air through a hose to the nose mask and keeps the upper airway open under
      continuous air pressure. This air pressure prevents obstructive sleep apnea, which occurs as
      a result of narrowing of the airway due to the relaxation of upper respiratory tract muscles
      during sleep. This machine helps to increase the oxygen flow by keeping the airway open.

      The BiPAP machine delivers two levels of pressure. Inspiratory Positive Airway Pressure
      (IPAP) is a high amount of pressure, applied when the patient inhales and a low Expiratory
      Positive Airway Pressure (EPAP) during exhalation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese children with Moderate to Severe Sleep Apnea will have baseline evaluation of markers
      of cardiometabolic risk and insulin resistance. Subjects will then use either the CPAP or
      BiPAP machine for 3 months and will return for another blood draw for measurement of the
      markers for cardiometabolic risk and insulin resistance.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Analysis was not done because only 1 subject was able to come back for the 3 month follow up
    visit.
  </why_stopped>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Level of Fasting Glucose</measure>
    <time_frame>baseline, 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Level of Fasting Insulin</measure>
    <time_frame>baseline, 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Level of Lipids</measure>
    <time_frame>baseline, 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <arm_group>
    <arm_group_label>CPAP/Bi-PAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP/BiPAP</intervention_name>
    <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
    <arm_group_label>CPAP/Bi-PAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Body mass index greater than 95th percentile for age and gender

          2. Moderate to severe obstructive sleep apnea (OSA) (as defined by an apnea-hypopnea
             index (AHI) score of â‰¥5 events per hour).

        Only patients who provide informed assent or consent and also have consent from a parent
        will be included.

        Exclusion Criteria:

          1. Predominant central sleep apnea

          2. Type 1 Diabetes

          3. Type 2 Diabetes

          4. Requires use of supplemental oxygen

          5. Active infection, cancer, or chronic inflammatory disorder

          6. Use of systemic steroids

          7. Simultaneous use of peroxisome proliferator-activated receptor (PPAR)-alpha (e.g.,
             gemfibrozil, fenofibrate) or PPAR-gamma (e.g., rosiglitazone, pioglitazone)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seema Kumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2011</study_first_posted>
  <results_first_submitted>April 14, 2014</results_first_submitted>
  <results_first_submitted_qc>April 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 13, 2014</results_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2014</last_update_posted>
  <responsible_party>
    <name_title>Seema Kumar, MD</name_title>
    <organization>Mayo Clinic</organization>
  </responsible_party>
  <keyword>Sleep Disordered Breathing</keyword>
  <keyword>CPAP</keyword>
  <keyword>BiPAP</keyword>
  <keyword>Cardiovascular risk markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>11 subjects with a high probability of Obstructive Sleep Apnea (OSA) were consented, and all had a baseline blood draw. 2 subjects had a normal sleep study. 9 subjects had a polysomnogram suggestive of OSA, and were given the intervention of 3 months of Continuous Positive Airway Pressure (CPAP) or Bi-Level Positive Airway Pressure (Bi-PAP) use.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CPAP/Bi-PAP</title>
          <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Screen Failure</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CPAP/Bi-PAP</title>
          <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Level of Fasting Glucose</title>
        <time_frame>baseline, 3 months</time_frame>
        <population>Only one participant returned for the 3 month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CPAP/Bi-PAP</title>
            <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Level of Fasting Glucose</title>
          <population>Only one participant returned for the 3 month visit.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Level of Fasting Insulin</title>
        <time_frame>baseline, 3 months</time_frame>
        <population>Only one participant returned for the 3 month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CPAP/Bi-PAP</title>
            <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Level of Fasting Insulin</title>
          <population>Only one participant returned for the 3 month visit.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Level of Lipids</title>
        <time_frame>baseline, 3 months</time_frame>
        <population>Only one participant returned for the 3 month visit.</population>
        <group_list>
          <group group_id="O1">
            <title>CPAP/Bi-PAP</title>
            <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Level of Lipids</title>
          <population>Only one participant returned for the 3 month visit.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CPAP/Bi-PAP</title>
          <description>Subjects will be treated with either CPAP or Bi-PAP for three months.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Analysis was not done because only 1 subject was able to come back for the 3 month follow up visit.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Seema Kumar</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>507-538-2724</phone>
      <email>kumar.seema@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

